The WACC of BioCryst Pharmaceuticals Inc (BCRX) is 8.8%.
| Range | Selected | |
| Cost of equity | 8.80% - 12.60% | 10.70% |
| Tax rate | 0.10% - 0.50% | 0.30% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 7.1% - 10.5% | 8.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.08 | 1.37 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.80% | 12.60% |
| Tax rate | 0.10% | 0.50% |
| Debt/Equity ratio | 0.57 | 0.57 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 7.1% | 10.5% |
| Selected WACC | 8.8% | |